{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:09:50Z","timestamp":1791500990518,"version":"4.3.4"},"reference-count":121,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2314-B-A49-044"],"award-info":[{"award-number":["111-2314-B-A49-044"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V112C-102"],"award-info":[{"award-number":["V112C-102"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jmii.2022.12.004","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T02:43:14Z","timestamp":1671072194000},"page":"442-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis"],"prefix":"10.1016","volume":"56","author":[{"given":"Shiang-Fen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0611-3757","authenticated-orcid":false,"given":"Alice","family":"Ying-Jung Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Shin-Jung Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Shan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2681-1616","authenticated-orcid":false,"given":"Te-Liang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5874-8685","authenticated-orcid":false,"given":"Hung Jui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2951-6679","authenticated-orcid":false,"given":"Tzong-Shiann","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Feng","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Tsung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1147","key":"10.1016\/j.jmii.2022.12.004_bib1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/postgradmedj-2020-138577","article-title":"COVID-19: current understanding of its pathophysiology, clinical presentation and treatment","volume":"97","author":"Parasher","year":"2021","journal-title":"Postgrad Med"},{"issue":"5","key":"10.1016\/j.jmii.2022.12.004_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with covid-19 pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.004_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jmii.2022.12.004_bib5","first-page":"e2295","article-title":"Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: a systematic review and meta-analysis","author":"Peng","year":"2021","journal-title":"Rev Med Virol"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myab064","article-title":"Aspergillosis: emerging risk groups in critically ill patients","volume":"60","author":"Kluge","year":"2021","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib7","article-title":"Pathogenesis of respiratory viral and fungal coinfections. Review","volume":"35","author":"Salazar","year":"2022","journal-title":"Clinical Microbiology Reveiws"},{"issue":"12","key":"10.1016\/j.jmii.2022.12.004_bib8","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical Mycology in cooperation with the mycoses study group education and research consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.jmii.2022.12.004_bib9","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/myc.13335","article-title":"ECMM\/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries","volume":"64","author":"Rudramurthy","year":"2021","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13613-021-00827-3","article-title":"New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU","volume":"11","author":"Hamam","year":"2021","journal-title":"Ann Intensive Care"},{"issue":"6","key":"10.1016\/j.jmii.2022.12.004_bib11","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib12","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1038\/s41467-021-24521-x","article-title":"SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance","volume":"12","author":"Robinot","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-020-00454-7","article-title":"Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.jmii.2022.12.004_bib14","doi-asserted-by":"crossref","unstructured":"S. Feys, S.M. Goncalves, M. Khan, S. Choi, B. Boeckx, D. Chatelain, et al., Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study, Lancet Respir Med, 10(12), Dec 2022, 1147-1159.","DOI":"10.1016\/S2213-2600(22)00259-4"},{"key":"10.1016\/j.jmii.2022.12.004_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8874339","article-title":"COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation","volume":"2021","author":"Aboudounya","year":"2021","journal-title":"Mediat Inflamm"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib16","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1080\/21505594.2019.1568174","article-title":"Galactosaminogalactan (GAG) and its multiple roles in Aspergillus pathogenesis","volume":"10","author":"Speth","year":"2019","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13073-018-0553-2","article-title":"Antifungal immune responses: emerging host-pathogen interactions and translational implications","volume":"10","author":"Kumar","year":"2018","journal-title":"Genome Med"},{"key":"10.1016\/j.jmii.2022.12.004_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.semcdb.2018.03.003","article-title":"Pattern recognition receptors in fungal immunity","volume":"89","author":"Patin","year":"2019","journal-title":"Semin Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.004_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.micinf.2010.10.005","article-title":"Aspergillus fumigatus cell wall components differentially modulate host TLR2 and TLR4 responses","volume":"13","author":"Chai","year":"2011","journal-title":"Microb Infect"},{"issue":"6","key":"10.1016\/j.jmii.2022.12.004_bib20","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood-2003-06-2186","article-title":"Interactions of Aspergillus fumigatus with endothelial cells: internalization, injury, and stimulation of tissue factor activity","volume":"103","author":"Lopes Bezerra","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2022.12.004_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jprot.2013.07.003","article-title":"Discovering the infectome of human endothelial cells challenged with Aspergillus fumigatus applying a mass spectrometry label-free approach","volume":"97","author":"Curty","year":"2014","journal-title":"J Proteonomics"},{"issue":"5","key":"10.1016\/j.jmii.2022.12.004_bib22","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s12276-021-00592-0","article-title":"Type I and III interferon responses in SARS-CoV-2 infection","volume":"53","author":"Kim","year":"2021","journal-title":"Exp Mol Med"},{"issue":"12","key":"10.1016\/j.jmii.2022.12.004_bib23","first-page":"219","article-title":"Impaired immune response drives age-dependent severity of COVID-19","author":"Beer","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.jmii.2022.12.004_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01858-22","article-title":"Longitudinal evaluation of the QuantiFERON-TB gold plus assay in hospitalized COVID-19 patients with a first indeterminate result: resolution of inflammation and restoration of T-lymphocyte counts and interferon-gamma production","author":"Alessio","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41421-022-00453-8","article-title":"Surface translocation of ACE2 and TMPRSS2 upon TLR4\/7\/8 activation is required for SARS-CoV-2 infection in circulating monocytes","volume":"8","author":"Yao","year":"2022","journal-title":"Cell Discov"},{"key":"10.1016\/j.jmii.2022.12.004_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cytogfr.2021.11.001","article-title":"SARS-CoV-2 infection and oxidative stress: pathophysiological insight into thrombosis and therapeutic opportunities","volume":"63","author":"Alam","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"10.1016\/j.jmii.2022.12.004_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061995","article-title":"Oxidative stress and new pathogenetic mechanisms in endothelial dysfunction: potential diagnostic biomarkers and therapeutic targets","volume":"9","author":"Scioli","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jmii.2022.12.004_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9764002","article-title":"Upregulation of PD-1 expression and high sPD-L1 levels associated with COVID-19 severity","volume":"2022","author":"Beserra","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jmii.2022.12.004_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.695242","article-title":"PD-L1 dysregulation in COVID-19 patients","volume":"12","author":"Sabbatino","year":"2021","journal-title":"Front Immunol"},{"issue":"24","key":"10.1016\/j.jmii.2022.12.004_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146701","article-title":"PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response","volume":"6","author":"Loretelli","year":"2021","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.jmii.2022.12.004_bib31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/infdis\/jix469","article-title":"Aspergillus fumigatus cell wall alpha-(1,3)-glucan stimulates regulatory T-cell polarization by inducing PD-L1 expression on human dendritic cells","volume":"216","author":"Stephen-Victor","year":"2017","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.jmii.2022.12.004_bib32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/infdis\/jiaa264","article-title":"Protective activity of programmed cell death protein 1 blockade and synergy with caspofungin in a murine invasive pulmonary aspergillosis model","volume":"222","author":"Wurster","year":"2020","journal-title":"J Infect Dis"},{"issue":"62","key":"10.1016\/j.jmii.2022.12.004_bib33","first-page":"6","article-title":"Autoantibodies neutralizing type I IFNs are present in \u223c4% of uninfected individuals over 70 years old and account for \u223c20% of COVID-19 deaths","author":"Bastard","year":"2021","journal-title":"Sci Immunol"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.004_bib34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2567.2010.03302.x","article-title":"Enhancement of anti-Aspergillus T helper type 1 response by interferon-beta-conditioned dendritic cells","volume":"131","author":"Gafa","year":"2010","journal-title":"Immunology"},{"issue":"7902","key":"10.1016\/j.jmii.2022.12.004_bib35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41586-022-04447-0","article-title":"Human genetic and immunological determinants of critical COVID-19 pneumonia","volume":"603","author":"Zhang","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.004_bib36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/bjh.17145","article-title":"Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study","volume":"193","author":"Marchesini","year":"2021","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.jmii.2022.12.004_bib37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/cid\/ciy175","article-title":"Serious infections in patients receiving ibrutinib for treatment of lymphoid cancer","volume":"67","author":"Varughese","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"23","key":"10.1016\/j.jmii.2022.12.004_bib38","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/bloodadvances.2019000930","article-title":"Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents","volume":"3","author":"Aldoss","year":"2019","journal-title":"Blood Adv"},{"issue":"18","key":"10.1016\/j.jmii.2022.12.004_bib39","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1158\/1078-0432.CCR-17-3761","article-title":"Comprehensive safety analysis of venetoclax monotherapy for patients with relapsed\/refractory chronic lymphocytic leukemia","volume":"24","author":"Davids","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.jmii.2022.12.004_bib40","article-title":"Invasive fungal infections and targeted therapies in hematological malignancies","volume":"7","author":"Little","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"7","key":"10.1016\/j.jmii.2022.12.004_bib41","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/502250","article-title":"Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case?","volume":"24","author":"De Rosa","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.jmii.2022.12.004_bib42","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3109\/s10165-011-0449-0","article-title":"Recurrent allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis treated with etanercept and tocilizumab","volume":"21","author":"Honda","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jmii.2022.12.004_bib43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4137\/CMAMD.S7371","article-title":"Safety and efficacy of tocilizumab for the treatment of rheumatoid arthritis","volume":"5","author":"Ogata","year":"2012","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"issue":"11","key":"10.1016\/j.jmii.2022.12.004_bib44","first-page":"636","article-title":"Interleukin 6 receptor inhibitor tocilizumab suppresses cytokine expression, inflammasome activation and phagocytosis in a cell model of sepsis","volume":"71","author":"Sheng","year":"2016","journal-title":"Pharmazie"},{"key":"10.1016\/j.jmii.2022.12.004_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.trsl.2016.12.003","article-title":"Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation","volume":"183","author":"Ruiz-Limon","year":"2017","journal-title":"Transl Res"},{"issue":"9","key":"10.1016\/j.jmii.2022.12.004_bib46","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/cmi.12616","article-title":"LC3-associated phagocytosis: a crucial mechanism for antifungal host defence against Aspergillus fumigatus","volume":"18","author":"Sprenkeler","year":"2016","journal-title":"Cell Microbiol"},{"issue":"12\u201313","key":"10.1016\/j.jmii.2022.12.004_bib47","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.micinf.2010.06.009","article-title":"NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus","volume":"12","author":"McCormick","year":"2010","journal-title":"Microb Infect"},{"key":"10.1016\/j.jmii.2022.12.004_bib48","article-title":"Complicated rheumatoid nodules in lung","volume":"2020","author":"Wickrematilake","year":"2020","journal-title":"Case Rep Rheumatol"},{"issue":"4","key":"10.1016\/j.jmii.2022.12.004_bib49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1189\/jlb.0207090","article-title":"Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis","volume":"82","author":"Orciuolo","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"2\u20133","key":"10.1016\/j.jmii.2022.12.004_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jsbmb.2010.03.058","article-title":"The role of the glucocorticoid receptor in inflammation and immunity","volume":"120","author":"Baschant","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"10.1016\/j.jmii.2022.12.004_bib51","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/cid\/ciu337","article-title":"Immune correlates of protection in human invasive aspergillosis","volume":"59","author":"Camargo","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2022.12.004_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954985","article-title":"COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds","volume":"13","author":"Tappe","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.jmii.2022.12.004_bib53","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/myc.13292","article-title":"Incidence and mortality of COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis","volume":"64","author":"Mitaka","year":"2021","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.jmii.2022.12.004_bib54","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s40121-021-00486-8","article-title":"Epidemiology and incidence of COVID-19-associated pulmonary aspergillosis (CAPA) in a Greek tertiary care academic reference hospital","volume":"10","author":"Paramythiotou","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"4","key":"10.1016\/j.jmii.2022.12.004_bib55","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3201\/eid2704.204895","article-title":"COVID-19-Associated pulmonary aspergillosis, march-august 2020","volume":"27","author":"Salmanton-Garcia","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.jmii.2022.12.004_bib56","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","article-title":"Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology","volume":"28","author":"Prattes","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.jmii.2022.12.004_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3201\/eid2711.211174","article-title":"Multinational observational cohort study of COVID-19\u2013associated pulmonary aspergillosis","volume":"27","author":"Janssen","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmii.2022.12.004_bib58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhin.2021.04.012","article-title":"Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review","volume":"113","author":"Chong","year":"2021","journal-title":"J Hosp Infect"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.004_bib59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s15010-021-01701-x","article-title":"Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis","volume":"50","author":"Chong","year":"2022","journal-title":"Infection"},{"key":"10.1016\/j.jmii.2022.12.004_bib61","doi-asserted-by":"crossref","unstructured":"W. Chen, C. Yin, M. Zhong, B. Hu, X. Gao, K. Zhang, et al., Incidence and outcomes of patients with COVID-19 associated pulmonary aspergillosis (CAPA) in intensive care units: a systematic review and meta-analysis of 31 cohort studies, Ann Palliat Med, 11(7), Jul 2022, 2202-2209.","DOI":"10.21037\/apm-21-2043"},{"issue":"9","key":"10.1016\/j.jmii.2022.12.004_bib62","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/myc.13328","article-title":"Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: a systematic review and meta-analysis","volume":"64","author":"Singh","year":"2021","journal-title":"Mycoses"},{"issue":"9","key":"10.1016\/j.jmii.2022.12.004_bib63","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/myc.13341","article-title":"A review of significance of Aspergillus detection in airways of ICU COVID-19 patients","volume":"64","author":"Pasquier","year":"2021","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.004_bib64","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1128\/Spectrum.01138-21","article-title":"COVID-19-Associated pulmonary aspergillosis, fungemia, and pneumocystosis in the intensive care unit: a retrospective multicenter observational cohort during the first French pandemic wave","volume":"9","author":"Bretagne","year":"2021","journal-title":"Microbiol Spectr"},{"issue":"10","key":"10.1016\/j.jmii.2022.12.004_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10100807","article-title":"Invasive pulmonary aspergillosis in patients with SARS-CoV-2 infection: a systematic review of the literature","volume":"10","author":"Apostolopoulou","year":"2020","journal-title":"Diagnostics"},{"issue":"3","key":"10.1016\/j.jmii.2022.12.004_bib66","article-title":"Routine surveillance of healthcare-associated infections misses a significant proportion of invasive aspergillosis in patients with severe COVID-19","volume":"8","author":"Ebner","year":"2022","journal-title":"J Fungi (Basel)"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.004_bib67","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/myc.13213","article-title":"Invasive pulmonary aspergillosis in the COVID-19 era: an expected new entity","volume":"64","author":"Machado","year":"2021","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.jmii.2022.12.004_bib68","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/myc.13430","article-title":"COVID-19-associated pulmonary aspergillosis in ICU patients in a German reference centre: phenotypic and molecular characterisation of Aspergillus fumigatus isolates","volume":"65","author":"Kirchhoff","year":"2022","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.004_bib69","article-title":"COVID-19 associated pulmonary aspergillosis: diagnostic performance, fungal epidemiology and antifungal susceptibility","volume":"8","author":"Lackner","year":"2022","journal-title":"J Fungi (Basel)"},{"issue":"3","key":"10.1016\/j.jmii.2022.12.004_bib70","article-title":"COVID-19 associated pulmonary aspergillosis (CAPA): hospital or home environment as a source of life-threatening Aspergillus fumigatus infection?","volume":"8","author":"Pelaez-Garcia de la Rasilla","year":"2022","journal-title":"J Fungi (Basel)"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.004_bib71","article-title":"Azole-resistant COVID-19-associated pulmonary aspergillosis in an immunocompetent host: a case report","volume":"6","author":"Meijer","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"3","key":"10.1016\/j.jmii.2022.12.004_bib72","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1128\/JCM.05946-11","article-title":"Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay","volume":"50","author":"Tortorano","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.jmii.2022.12.004_bib73","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.jmii.2022.12.004_bib74","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.jmii.2022.12.004_bib75","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jmii.2022.12.004_bib76","doi-asserted-by":"crossref","first-page":"e3606","DOI":"10.1093\/cid\/ciaa1065","article-title":"Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: a prospective study","volume":"73","author":"Bartoletti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2022.12.004_bib77","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.3389\/fmicb.2019.02903","article-title":"A new age in molecular diagnostics for invasive fungal disease: are we ready?","volume":"10","author":"Kidd","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmii.2022.12.004_bib78","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fmicb.2018.00515","article-title":"Molecular detection of azole-resistant Aspergillus fumigatus in clinical samples","volume":"9","author":"Buil","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmii.2022.12.004_bib79","doi-asserted-by":"crossref","unstructured":"H. Lamberink, A. Wagemakers, K.C.E. Sigaloff, R. van Houdt, N.A. de Jonge and K. van Dijk, The impact of the updated EORTC\/MSG criteria on the classification of hematological patients with suspected invasive pulmonary aspergillosis, Clin Microbiol Infect, 28(8), Aug 2022,1120-1125.","DOI":"10.1016\/j.cmi.2022.02.026"},{"issue":"3","key":"10.1016\/j.jmii.2022.12.004_bib80","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/JCM.03216-14","article-title":"Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid","volume":"53","author":"Chong","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.004_bib81","article-title":"Evaluation of three commercial PCR assays for the detection of azole-resistant Aspergillus fumigatus from respiratory samples of immunocompromised patients","volume":"7","author":"Scharmann","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jmii.2022.12.004_bib82","author":"Giacobbe","year":"2022","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib83","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib84","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19-associated pulmonary aspergillosis","volume":"202","author":"van Arkel","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib85","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-021-03753-9","article-title":"Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study","volume":"25","author":"Hatzl","year":"2021","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib86","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13054-021-03728-w","article-title":"Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis\/aspergillus tracheobronchitis","volume":"25","author":"Van Ackerbroeck","year":"2021","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.jmii.2022.12.004_bib87","article-title":"Innate and adaptive immunity to Mucorales","volume":"3","author":"Ghuman","year":"2017","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib88","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/lio2.727","article-title":"A potential head and neck problem in COVID-19 patients","volume":"7","author":"Abdel-Aziz","year":"2022","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"11","key":"10.1016\/j.jmii.2022.12.004_bib89","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.cmet.2021.09.009","article-title":"Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2","volume":"33","author":"Reiterer","year":"2021","journal-title":"Cell Metabol"},{"issue":"6","key":"10.1016\/j.jmii.2022.12.004_bib90","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1288\/00005537-199206000-00011","article-title":"Intracranial complications of mucormycosis: an experimental model and clinical review","volume":"102","author":"Anand","year":"1992","journal-title":"Laryngoscope"},{"issue":"11","key":"10.1016\/j.jmii.2022.12.004_bib91","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/myc.13351","article-title":"Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: an observational study","volume":"64","author":"Avatef Fazeli","year":"2021","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.jmii.2022.12.004_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.102196","article-title":"Diabetes, COVID 19 and mucormycosis: clinical spectrum and outcome in a tertiary care medical center in Western India","volume":"15","author":"Mishra","year":"2021","journal-title":"Diabetes Metabol Syndr"},{"issue":"4","key":"10.1016\/j.jmii.2022.12.004_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metabol Syndr"},{"issue":"7","key":"10.1016\/j.jmii.2022.12.004_bib94","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jmii.2022.12.004_bib95","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis","volume":"20","author":"Moorthy","year":"2021","journal-title":"J Maxillofac Oral Surg"},{"issue":"10","key":"10.1016\/j.jmii.2022.12.004_bib96","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/myc.13334","article-title":"Mucormycosis in patients with COVID-19: a cross-sectional descriptive multicentre study from Iran","volume":"64","author":"Pakdel","year":"2021","journal-title":"Mycoses"},{"issue":"5","key":"10.1016\/j.jmii.2022.12.004_bib97","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum","volume":"135","author":"Sharma","year":"2021","journal-title":"J Laryngol Otol"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.004_bib98","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/ijo.IJO_3774_20","article-title":"Mucor in a viral land: a tale of two pathogens","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol. Feb"},{"issue":"6","key":"10.1016\/j.jmii.2022.12.004_bib99","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/ijp.ijp_839_21","article-title":"COVID-19-associated rhino-orbital-cerebral mucormycosis: a systematic review, meta-analysis, and meta-regression analysis","volume":"53","author":"Bhattacharyya","year":"2021","journal-title":"Indian J Pharmacol"},{"issue":"15","key":"10.1016\/j.jmii.2022.12.004_bib100","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.jmii.2022.12.004_bib101","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1111\/febs.15491","article-title":"COVID-19, cilia, and smell","volume":"287","author":"Li","year":"2020","journal-title":"FEBS J"},{"key":"10.1016\/j.jmii.2022.12.004_bib102","doi-asserted-by":"crossref","unstructured":"M. Hoenigl, D. Seidel, A. Carvalho, S.M. Rudramurthy, A. Arastehfar, J.P. Gangneux, et al., The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries, Lancet Microbe, 3 (7), July 2022, e543-e552.","DOI":"10.1016\/S2666-5247(21)00237-8"},{"issue":"12","key":"10.1016\/j.jmii.2022.12.004_bib103","article-title":"Hyperferritinemia and the extent of mucormycosis in COVID-19 patients","volume":"13","author":"Bhadania","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib104","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11033-021-06862-4","article-title":"COVID-19-associated-mucormycosis: possible role of free iron uptake and immunosuppression","volume":"49","author":"Tabassum","year":"2022","journal-title":"Mol Biol Rep"},{"issue":"10","key":"10.1016\/j.jmii.2022.12.004_bib105","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jiph.2021.09.004","article-title":"COVID19 associated mucormycosis: is GRP78 a possible link?","volume":"14","author":"Gumashta","year":"2021","journal-title":"J Infect Public Health"},{"issue":"4","key":"10.1016\/j.jmii.2022.12.004_bib106","first-page":"504","article-title":"Mucormycosis in COVID-19: a systematic review of literature","volume":"29","author":"Nagalli","year":"2021","journal-title":"Inf Med"},{"issue":"2","key":"10.1016\/j.jmii.2022.12.004_bib107","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00251-021-01226-5","article-title":"Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India","volume":"74","author":"Singh","year":"2022","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jmii.2022.12.004_bib108","article-title":"Biological attributes of age and gender variations in Indian COVID-19 cases: a retrospective data analysis","volume":"11","author":"Kushwaha","year":"2021","journal-title":"Clin Epidemiol Glob Health"},{"issue":"12","key":"10.1016\/j.jmii.2022.12.004_bib109","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/myc.13338","article-title":"COVID-19-associated mucormycosis: an updated systematic review of literature","volume":"64","author":"Pal","year":"2021","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.jmii.2022.12.004_bib110","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/jmv.27522","article-title":"Mucormycosis in COVID-19 recovered patients","volume":"94","author":"Kumar","year":"2022","journal-title":"J Med Virol"},{"issue":"Suppl 1","key":"10.1016\/j.jmii.2022.12.004_bib111","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1093\/cid\/cir868","article-title":"Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)","volume":"54","author":"Walsh","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib112","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1067\/j.cpradiol.2021.09.004","article-title":"Magnetic resonance imaging in coronavirus disease - 2019 associated rhino-orbital-cerebral mucormycosis (CA-ROCM) - imaging analysis of 50 consecutive patients","volume":"51","author":"Yadav","year":"2022","journal-title":"Curr Probl Diagn Radiol"},{"issue":"1127","key":"10.1016\/j.jmii.2022.12.004_bib113","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210648","article-title":"Spectrum of MR imaging findings of sinonasal mucormycosis in post COVID-19 patients","volume":"94","author":"Kondapavuluri","year":"2021","journal-title":"Br J Radiol"},{"issue":"10","key":"10.1016\/j.jmii.2022.12.004_bib114","doi-asserted-by":"crossref","first-page":"784 e27","DOI":"10.1016\/j.crad.2021.07.002","article-title":"Imaging findings using a combined MRI\/CT protocol to identify the \"entire iceberg\" in post-COVID-19 mucormycosis presenting clinically as only \"the tip","volume":"76","author":"Desai","year":"2021","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jmii.2022.12.004_bib115","doi-asserted-by":"crossref","unstructured":"L. Millon, D. Caillot, A. Berceanu, S. Bretagne, F. Lanternier, F. Morio, et al., Evaluation of serum Mucorales PCR for the diagnosis of Mucormycoses: the MODIMUCOR prospective trial, Clin Infect Dis, 75 (5), Sep 14 2022, 777-785.","DOI":"10.1093\/cid\/ciab1066"},{"issue":"4","key":"10.1016\/j.jmii.2022.12.004_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.06.006","article-title":"Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit","volume":"15","author":"Mulakavalupil","year":"2021","journal-title":"Diabetes Metabol Syndr"},{"issue":"3","key":"10.1016\/j.jmii.2022.12.004_bib117","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.jmii.2022.12.004_bib118","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jmii.2022.12.004_bib119","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/myc.13379","article-title":"Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals","volume":"65","author":"Seidel","year":"2022","journal-title":"Mycoses"},{"issue":"9","key":"10.1016\/j.jmii.2022.12.004_bib120","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.jmii.2022.12.004_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009921","article-title":"COVID-19-associated mucormycosis: evidence-based critical review of an emerging infection burden during the pandemic's second wave in India","volume":"15","author":"Aranjani","year":"2021","journal-title":"PLoS Neglected Trop Dis"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222002857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222002857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:29:23Z","timestamp":1761658163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118222002857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":121,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1684118222002857"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2022.12.004","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2022.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}